CVE-2022-35782

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35783, CVE-2022-35784, CVE-2022-35785, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35783

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35784, CVE-2022-35785, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35784

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35785, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35785

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35784, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35786

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35784, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35787

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35784, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35788

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35784, CVE ...

Continue Reading

CVSS3 - MEDIUM

CVE-2022-35789

Azure Site Recovery Elevation of Privilege Vulnerability. This CVE ID is unique from CVE-2022-35774, CVE-2022-35775, CVE-2022-35780, CVE-2022-35781, CVE-2022-35782, CVE-2022-35783, CVE-2022-35784, CVE ...

Continue Reading

CVSS3 - MEDIUM

Back to Main

Subscribe for the latest news: